MRM

TOKYO, May 28, 2026 (GLOBE NEWSWIRE) -- This report presents an overview of our business performance and key performance indicators (KPIs) for the first quarter of 2026 (January–March 2026). It also highlights trends over the past five quarters (2025Q1–2026Q1) to provide investors with a broader perspective. Data includes salons with comparable financial and customer metrics. 1. Salon Operation Business In 2026Q1, our salon business recorded an Average Revenue Per Customer of 7,822 JPY (+7.7% YoY), exceeding the Japanese industry average of 4,806 JPY by approximately 3,016 JPY.(*1) This performance reflects the strength of our service offering, supported by our training infrastructure and an educational curriculum refined over 25 years. Over 120 diverse training courses(Technical skills, Hospitality, Knowledge, Management)Continuous training system even after therapist debut Strategy Update: Hybrid Staffing Model In addition, to support sustainable growth in our store operations and further enhance service quality, we have been strategically upgrading the working styles of our store staff (therapists) since 2025. In addition to traditional employment models centered on hourly wages and fixed salaries, we have been promoting the adoption and expansion of a professional contractor (independent contractor) model. Key Performance Indicators (KPIs) *(1) Industry Average: Weighted average calculated based on data published by Recruit Co., Ltd., Hot Pepper Beauty Academy, “Beauty Census 2024 First Half (Relaxation Salon Edition) Report.”*(2) Number of Salons: Total number of directly operated and franchise salons at the end of each quarter.*(3) Total Customers: Number of customers visiting the salons.*(4) Revenue Per Customer: Average revenue calculated by dividing total sales by the number of customers.*(5) Repeat Ratio: Ratio of repeat customers to total customers.*(6) Operating Ratio: Ratio of treatment time to total working hours of therapists (excluding break times). The average number of stores included in the data aggregation for each quarter was 284 in 25Q1, 281 in 25Q2, 276 in 25Q3, 273 in 25Q4, and 268 in 26Q1. As a result of advancing both the transition to contractor agreements and the hiring of independent contractors, the proportion of independent contractors among therapists reached 45.1% as of Q1 2026, an increase from 29.8% in the same period of the previous year (*7). (*7) The number of therapists includes employees and independent contractors who worked as of the end of March 2025 and March 2026, respectively, at MEDIROM Wellness Co., Ltd. and SAWAN Co., Ltd. Furthermore, to support sustainable growth in our salon business and enhance service quality, we have been implementing a strategic update to our staffing model since 2025. In addition to the conventional employment model based on hourly and fixed wages, we have been expanding the use of professional contractor (independent contractor) arrangements. As a result, independent contractors accounted for 53% of our total workforce as of the end of the first quarter. This model introduces a performance-based compensation structure without fixed salary caps, allowing therapists to better align their earnings with their efforts. We believe this approach supports higher motivation and contributes to improved retention. Through this hybrid staffing structure, we aim to build a foundation that enables diverse talent to thrive over the long term while maintaining stable KPI performance. Looking ahead, we plan to continue to optimize this hybrid staffing model to further enhance therapist earnings. At the same time, we aim to strengthen our high-value, high-margin business model and enhance our corporate value over the medium to long term. 2. World ID World ID is a global digital identity protocol developed by Tools for Humanity, co-founded by Sam Altman and Alex Blania, to provide “Proof of Personhood” in the age of AI. In February 2026, we commenced a strategic partnership with Tools for Humanity under a Master Service Agreement. As part of this initiative, we have continued to deploy Orb devices primarily at Re.Ra.Ku® locations, resulting in approximately 31,000 total verifications as of the end of 2026Q1. The decrease in authentication numbers during the first quarter was mainly due to the January–March period being a seasonal slow period, combined with a lower number of business operating days. World ID Verification Trends *(8) New Verifications: Number of first-time World ID verifications recorded in each quarter. World ID Promotion Event Highlights The "Free 5-Minute Shoulder Massage" at the storefront has become a popular attraction. 3. HealthTech Business (Lav®) Our HealthTech division offers “Lav®,” a fully remote Specified Health Guidance service delivered through web-based interviews and app-based chat functions. Therapists from our Re.Ra.Ku® salons also serve as Lav® coaches, creating operational synergies across our businesses. This structure reduces the need for external recruitment and provides additional income opportunities for therapists, contributing to a high-margin business model. As of 2026Q1, we serve 106 health insurance providers, with cumulative users reaching 13,226. Specified Health Guidance is a support program designed to prevent lifestyle-related diseases associated with factors such as unbalanced diet, lack of sleep, insufficient exercise, smoking, and stress. Based on the results of “Specified Health Checkups”—health examinations focused on metabolic syndrome for individuals aged 40 to 74—specialized staff, including public health nurses and registered dietitians, provide guidance to help high-risk individuals review and improve their lifestyle habits. Since April 2008, medical insurers, including National Health Insurance and employee health insurance providers, have been required to implement both “Specified Health Checkups” and “Specified Health Guidance.” The Ministry of Health, Labour and Welfare has set national targets of at least 70% for health checkup participation and 45% for health guidance participation among eligible individuals. However, actual rates for fiscal year 2021 were 56.5% and 24.6%, respectively, indicating significant room for future market expansion. The adoption of ICT in Specified Health Guidance has been increasing steadily, and in recent years—partly driven by the COVID-19 pandemic—the adoption rate has exceeded 50% (according to the Japan Health Guidance Association). We have been operating in the Specified Health Guidance business within the ICT sector since fiscal year 2019. As of the end of March 2026, we have established partnerships with 106 insurers, and the cumulative number of users has surpassed 13,000, reaching a total of 13,226. Furthermore, we are expanding our business to meet the diversifying needs of health insurance associations by seeking to grow our new contracts for voluntary lifestyle improvement programs. These programs target younger individuals under the age of 40, extending beyond the standard age range for Specified Health Guidance (40 and older). The coaches responsible for Lav® program guidance are primarily comprised of active therapists from our salon business (Re.Ra.Ku® Group). By establishing a system where existing group staff can participate as coaches, we reduce new recruitment costs for coaches and can further our efforts to achieve a profitability model. Consequently, therapists who serve as coaches receive higher compensation, which effectively boosts their overall income. Since this coaching role is exclusively available to therapists currently working at Re.Ra.Ku®, the model encourages long-term retention, particularly among high-earning therapists. Our core Re.Ra.Ku® business and the Lav® business create close internal synergies, and this overall business model structure serves as one of our key competitive advantages. HealthTech KPI Trends *(9) Cumulative Users: The cumulative number of eligible individuals who have started using Specified Health Guidance. The Year-on-Year (YoY) Change/Increase reflects the difference in the cumulative total compared to the 2025 Q1 level. Forward-Looking Statements Regarding MEDIROM Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “designate,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include: MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives, including the full-scale adoption of World ID and deployment of Orb authentication terminals across 3,000 locations, and achieving its targeted number of verifications; the MSA being early terminated by the World parties for convenience or any other reason; Changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets; MEDIROM’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment; the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies; MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property; MEDIROM’s ability to raise additional capital on acceptable terms or at all; MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments; changes in consumer preferences and MEDIROM’s competitive environment; MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and the regulatory environment in which MEDIROM operates. More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future. About MEDIROM Group MEDIROM Group operates approximately 287 wellness salons under the “Re.Ra.Ku®” brand nationwide. Since 2015, we have expanded into HealthTech, offering on-demand training apps like Lav® for specific health guidance and lifestyle improvement programs. In 2020, we started manufacturing the 24/7 recharge-free smart tracker “MOTHER Bracelet®,” which is now used in REMONY, our remote monitoring system for various industries including caregiving, transportation, construction, and manufacturing. About MEDIROM Healthcare Technologies Inc.NASDAQ Symbol: MRMTradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, JapanWebsite: https://medirom.co.jp/enContact: [email protected] Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1cf9428f-cff5-427c-bb4b-354431671f12 https://www.globenewswire.com/NewsRoom/AttachmentNg/78f2aa59-849f-4774-923f-936c190f83e8 https://www.globenewswire.com/NewsRoom/AttachmentNg/7716135e-4834-4e5c-9cf6-bbc1f8c27a55 https://www.globenewswire.com/NewsRoom/AttachmentNg/813811db-7d96-403a-a6d3-86af55b8315e https://www.globenewswire.com/NewsRoom/AttachmentNg/b48c4330-d9dd-460b-881a-c4b35b4c2dc9 https://www.globenewswire.com/NewsRoom/AttachmentNg/49c24fce-259f-4b56-aee2-83f9eca07fa5 https://www.globenewswire.com/NewsRoom/AttachmentNg/fe2abb98-c341-4bf5-b1fb-488c71fdbffb https://www.globenewswire.com/NewsRoom/AttachmentNg/5a5185b6-9b06-4ca1-8f68-cb98917b0d0b https://www.globenewswire.com/NewsRoom/AttachmentNg/54c591b0-9d75-4c0a-9ef0-9d8a614fb86b https://www.globenewswire.com/NewsRoom/AttachmentNg/6b089036-a488-4f5d-9cf8-e7a93198e8f8

Total Revenue: Increased by 21.5% to JPY52.7 million. Cost of Revenue Ratio: Decreased from 77% in 2023 to 72.9% in 2024. SG&A Expenses: Increased by 14.3%. Net Income: Increased by 20.1% to JPY0.9 million. Cash Flow from Operating Activities: JPY8.5 million. Cash Flow from Investing Activities: JPY2.3 million. Cash Flow from Financing Activities: JPY7.6 million. Adjusted EBITDA: Improved to JPY2.7 million. Adjusted EBITDA Margin: Improved to 5%. Net Cash and Cash Equivalents: Increased by JPY1.4 million. Average Revenue per Customer: Grew by 3.9%. Number of Salon Locations: Increased to 60 from 38 in the previous year. Warning! GuruFocus has detected 7 Warning Signs with MRM. Release Date: May 21, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Total revenue increased by 21.5% due to higher sales of salons and outsourcing revenues. Net income rose by 20.1%, driven by gains from sales of loans and tax asset valuation allowances. Adjusted EBITDA improved to JPY2.7 million with a margin increase to 5%. Average revenue per customer grew by 3.9%, indicating enhanced customer engagement. Expansion in the digital preventive healthcare segment with the upgraded LAB application and Mother bracelet. Cost of revenue increased by 15.1% due to salon purchase-back transactions. SG&A expenses rose by 14.3%, attributed to higher professional fees and recruiting expenses. Impairment loss recorded due to expected salon closures in 2025. Increased reliance on short-term and long-term bank loans for financing activities. Potential risks associated with global expansion and franchising plans. Q: Can you provide an overview of Medirom's financial performance in 2024? A: Fumitoshi Fujiwara, Chief Financial Officer, reported that total revenue increased by 21.5% to JPY52.7 million, driven by increased sales of salons and store operations outsourcing revenues. The cost of revenue ratio decreased from 77% in 2023 to 72.9% in 2024. Net income rose by 20.1% to JPY0.9 million, primarily due to gains from sales of loans and tax asset valuation allowances. Q: What were the key drivers of cash flow in 2024? A: Cash flow from operating activities was JPY8.5 million, mainly due to decreased accrued expenses and reclassification of PCs. Cash flow from investing activities was JPY2.3 million, attributed to proceeds from salon sales. Cash flow from financing activities was JPY7.6 million, driven by proceeds from stock issuance and loans. Q: What are Medirom's strategic plans for 2025? A: The company plans to increase the number of salons, particularly those at spa facilities, and grow its digital preventive health segment. They aim to expand the user base for their LAB application and accelerate production of the Mother bracelet. Global expansion opportunities and cost-cutting measures at salons are also part of the strategy. Q: How does Medirom plan to enhance its digital preventive healthcare segment? A: Medirom intends to grow this segment by increasing the number of users accessing the specific health guidance program through their LAB application. They also plan to expand the billing user base for the app and accelerate production of the Mother bracelet for corporate clients. Q: What are the company's plans regarding global expansion? A: Medirom is considering global expansion opportunities, particularly through franchising or partnership options for its salon business and a B2B2C distribution model for the Mother bracelet. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.

TOKYO, May 20, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”), today announced that for the year ended December 31, 2024, the Company had total revenue of $52,736,000, a 22% increase over total revenue of $43,388,000 for the year ended December 31, 2023. (The Company reports its financial results in Japanese yen and figures presented in this press release in US dollars have been translated for convenience at the exchange rate of ¥ 157.37 = US$1.00. See “Convenience Translations to US Dollars” below for more information.) Net income for 2024 was $878,000, or $0.17 per basic share, a 20% improvement compared with net income of $731,000, or $0.15 per basic share, for 2023. MEDIROM’s improvement in revenue in 2024 was primarily driven by a 23% increase in the Company’s Relaxation Salon Segment revenue to $47,317,000, compared with $38,507,000 in 2023. The Company’s increase in net income in 2024 was primarily the result of the rise in total revenue, a decrease in cost of revenues as a percentage of total revenues to 72.9% in 2024 compared with 77.0% during 2023, and a decrease in selling, general and administrative expenses as a percentage of total revenues to 27.0% in 2024 compared with 28.7% in 2023. As of December 31, 2024, MEDIROM had cash and cash equivalents of $2,093,000, compared with $676,000 as of December 31, 2023. The Company’s total indebtedness was $11,925,000 and $9,857,000 as of December 31, 2024 and 2023, respectively. Net cash used in operating activities was $8,462,000 in 2024 compared with $4,014,000 in 2023. Net cash provided in investing activities was $2,296,000 in 2024 while the Company had net cash used in investing activities of $2,088,000 in 2023. Net cash provided by financing activities was $7,583,000 in 2024 compared with $2,931,000 in 2023. Basic weighted average common shares outstanding were 5,107,404 in 2024 and 4,882,500 in 2023. “Thus far in 2025, MEDIROM has announced several notable developments,” said Chief Executive Officer Koji Eguchi. “In January, the Company’s subsidiary, MEDIROM MOTHER Labs Inc., began providing its remote health monitoring system, REMONY, and charging-free smart tracker device, MOTHER Bracelet®︎, to the Electronics Division of TOPPAN Inc. Also in January, all corporate capital registration procedures under Japanese law were completed with respect to the Company’s offering of 2,860,000 common shares represented by American Depositary Shares, generating gross proceeds of approximately $5 million.” “In March, Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc., made a second investment in Mother Labs’ Series A financing at a pre-money valuation of approximately $60 million. This new investment followed Mr. Hayami’s initial investment in a Series A financing in December 2024. Also in March, MEDIROM obtained a new unsecured short-term bank loan in the amount of approximately $2.4 million, which is being used for repayment of indebtedness to MEDIROM Mother Labs and for general working capital, including MOTHER Bracelet development.” Looking forward to the rest of 2025, Mr. Eguchi said that MEDIROM “will continue to strive to improve revenue growth and bottom-line performance for the year.” Mr. Eguchi added, “As for near-term goals, we aim to not only to capture a significant share of the existing Japanese market for relaxation salons but also to expand our Digital Preventative Healthcare business lines through a variety of strategic initiatives and to increase the margin in that segment. As part of this, we intend to increase the number of Lav® users via the Specific Health Guidance Program promoted by the Ministry of Health, Labor and Welfare of Japan and expand the billing user base for the upgraded Lav® application. We also intend to accelerate the production of our MOTHER Bracelet® for large orders from corporate clients.” On April 29, 2025, the Company filed its most recent annual report on Form 20-F, which annual report covers the Company’s financial results for the 2024 fiscal year and is available on the Securities and Exchange Commission website at www.sec.gov. Convenience Translations to US Dollars The Company’s financial results presented in this press release in US dollars have been translated for convenience from Japanese yen at the exchange rate of ¥ 157.37 = US$1.00, which was the foreign exchange rate on December 31, 2024, as reported by the Board of Governors of the Federal Reserve System in its weekly release on January 6, 2025. These financial results, as reported by the Company in Japanese yen, are included in the tabular data at the end of this press release. Webcast MEDIROM will hold a webcast to discuss the Company’s financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21 at 8:30 am Eastern time. To access the webcast, please go to the following URL five to ten minutes prior to its start: https://event.choruscall.com/mediaframe/webcast.html?webcastid=9rHZ3uFf To participate in the webcast, please use the following dial-in numbers: Conference Replay: A replay of this call will be available on May 21, 2025 at 11:30 a.m. ET until June 4, 2025, at 11:59 PM ET. To access the replay, please dial: To access the replay using an international dial-in number, please select the following link: https://services.choruscall.com/ccforms/replay.html About MEDIROM Healthcare Technologies Inc. MEDIROM, a holistic healthcare company, operates 307 (as of March 31, 2025) relaxation salons across Japan, Re.Ra.Ku® being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called “Lav®”, which is developed by the Company. MEDIROM also entered the device business in 2020 and has developed a smart tracker “MOTHER Bracelet®”. In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en. Forward-Looking Statements Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include: the Company’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives; the Company’s ability to sell certain of its owned salons to investors, and receive management fees from such sold salons, on acceptable terms; changes in Japanese and global economic conditions and financial markets, including their effects on the Company’s expansion in Japan and certain overseas markets; the Company’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment; the fluctuation of foreign exchange rates, which affects the Company’s expenses and liabilities payable in foreign currencies; the Company’s ability to hire and train a sufficient number of therapists and place them at salons in need of additional staffing; changes in demographic, unemployment, economic, regulatory or weather conditions affecting the Tokyo region of Japan, where the Company’s relaxation salon base is geographically concentrated; the Company’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property; the financial performance of the Company’s franchisees and the Company’s limited control with respect to their operations; the Company’s ability to raise additional capital on acceptable terms or at all; the Company’s level of indebtedness and potential restrictions on the Company under the Company’s debt instruments; changes in consumer preferences and the Company’s competitive environment; the Company’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and the regulatory environment in which the Company operates. More information on these risks and other potential factors that could affect the Company’s business, reputation, results of operations, financial condition, and stock price is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of the Company’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. The Company assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future. Contact: Investor Relations Team [email protected] The financial information below should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 20-F for the year ended December 31, 2024 (the “Audited Financial Statements”), which is available on the Securities and Exchange Commission website at www.sec.gov.

TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”) today announced that it will host a webcast to review the Company’s financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21, 2025 at 8:30 am Eastern Time. The Company will issue a press release discussing those results after the market close on Tuesday, May 20th, 2025. In addition, on April 29, 2025, the Company filed its most recent annual report on Form 20-F, which annual report covers the Company’s financial results for the 2024 fiscal year and is available on the Securities and Exchange Commission website at www.sec.gov. To access the webcast, please go to the following URL five to ten minutes prior to its start: https://event.choruscall.com/mediaframe/webcast.html?webcastid=9rHZ3uFf To participate in the webcast, please use the following dial-in numbers: Conference Replay: A replay of this call will be available on May 21, 2025 at 11:30 a.m. ET until June 4, 2025, at 11:59 PM ET. To access the replay, please dial: To access the replay using an international dial-in number, please select the following link: https://services.choruscall.com/ccforms/replay.html About MEDIROM Healthcare Technologies Inc. MEDIROM, a holistic healthcare company, operates 307 (as of March 31, 2025) relaxation salons across Japan, Re.Ra.Ku® being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called “Lav®”, which is developed by the Company. MEDIROM also entered the device business in 2020 and has developed a smart tracker “MOTHER Bracelet®”. In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en. Forward-Looking Statements Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include: the Company’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives; the Company’s ability to sell certain of its owned salons to investors, and receive management fees from such sold salons, on acceptable terms; changes in Japanese and global economic conditions and financial markets, including their effects on the Company’s expansion in Japan and certain overseas markets; the Company’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment; the fluctuation of foreign exchange rates, which affects the Company’s expenses and liabilities payable in foreign currencies; the Company’s ability to hire and train a sufficient number of therapists and place them at salons in need of additional staffing; changes in demographic, unemployment, economic, regulatory or weather conditions affecting the Tokyo region of Japan, where the Company’s relaxation salon base is geographically concentrated; the Company’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property; the financial performance of the Company’s franchisees and the Company’s limited control with respect to their operations; the Company’s ability to raise additional capital on acceptable terms or at all; the Company’s level of indebtedness and potential restrictions on the Company under the Company’s debt instruments; changes in consumer preferences and the Company’s competitive environment; the Company’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and the regulatory environment in which the Company operates. More information on these risks and other potential factors that could affect the Company’s business, reputation, results of operations, financial condition, and stock price is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of the Company’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. The Company assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future. Contact: Investor Relations Team [email protected]